Neurodegenerative Disease
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
Human Skin Cells Reprogramming Creates New Neurodegenerative Model For Huntington’s Disease
2022-08-31
Pfizer, Lilly-Backed Neuro Company Bags $64 Million Series B To Correct Progranulin Deficiency in Dementia
2022-02-11
Japan’s Ono Pharmaceutical Expands Collab with Neurimmune to Discover Antibodies for Neurodegenerative Disorders
2022-01-18